GA, D., JC, v. K., LM, W., C, S., KW, M., C, M., & IM, M. (2019). Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: A Theranostic for Acute Stroke. Translational stroke research, 10(5), 583. https://doi.org/10.1007/s12975-018-0679-y
Chicago Style (17th ed.) CitationGA, Deuchar, van Kralingen JC, Work LM, Santosh C, Muir KW, McCabe C, and Macrae IM. "Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: A Theranostic for Acute Stroke." Translational Stroke Research 10, no. 5 (2019): 583. https://doi.org/10.1007/s12975-018-0679-y.
MLA (9th ed.) CitationGA, Deuchar, et al. "Preclinical Validation of the Therapeutic Potential of Glasgow Oxygen Level Dependent (GOLD) Technology: A Theranostic for Acute Stroke." Translational Stroke Research, vol. 10, no. 5, 2019, p. 583, https://doi.org/10.1007/s12975-018-0679-y.